Search alternatives:
significantly increased » significant increase (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
shape decrease » shape increases (Expand Search), small decrease (Expand Search), step decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
significantly increased » significant increase (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
shape decrease » shape increases (Expand Search), small decrease (Expand Search), step decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
-
1961
-
1962
-
1963
Characteristics of patients at risk of pneumococcal disease in France in 2020 and vaccination rates.
Published 2025Subjects: -
1964
Volume distribution and sentiment of positive, negative, and neutral tweets.
Published 2025Subjects: -
1965
Shape rescue in the midface phenotype in the Dp(16)1Yey/ <i>Ripply3</i><sup><i>tm1b</i></sup> compound mutant.
Published 2025“…In light blue, the structures with no significant changes. On the left, the histogram of every point distance evaluated (in this case, more than 1.238.684 points) and the surface differences with the color code for the increase-decrease dimensions (Red to green).…”
-
1966
KO of iPLA<sub>2</sub>γ attenuates development of albuminuria in STZ-induced diabetic nephropathy.
Published 2024Subjects: -
1967
-
1968
Control (Ctrl) GECs are more susceptible to injury compared to iPLA<sub>2</sub>γ KO GECs.
Published 2024Subjects: -
1969
Podocyte numbers in control and iPLA<sub>2</sub>γ KO mice (WT1-positive cells).
Published 2024Subjects: -
1970
-
1971
Kaplan-Meier curves and time-dependent Cox regression for outcome of mortality.
Published 2024Subjects: -
1972
Cox regression models for adverse cardiovascular events (ACE) and individual components of ACE.
Published 2024Subjects: -
1973
-
1974
Baseline demographics and comorbidities by presence of post-treatment adverse cardiovascular events.
Published 2024Subjects: -
1975
-
1976
-
1977
-
1978
-
1979
-
1980